Cargando…

Improvements in the Life Expectancy of Type 1 Diabetes: The Pittsburgh Epidemiology of Diabetes Complications Study Cohort

Survival in type 1 diabetes has improved, but the impact on life expectancy in the U.S. type 1 diabetes population is not well established. Our objective was to estimate the life expectancy of the Pittsburgh Epidemiology of Diabetes Complications (EDC) study cohort and quantify improvements by compa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miller, Rachel G., Secrest, Aaron M., Sharma, Ravi K., Songer, Thomas J., Orchard, Trevor J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2012
Materias:	Complications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3478551/ https://www.ncbi.nlm.nih.gov/pubmed/22851572 http://dx.doi.org/10.2337/db11-1625

Ejemplares similares

Changing Impact of Modifiable Risk Factors on the Incidence of Major Outcomes of Type 1 Diabetes: The Pittsburgh Epidemiology of Diabetes Complications Study
por: Miller, Rachel G., et al.
Publicado: (2013)

Cause-Specific Mortality Trends in a Large Population-Based Cohort With Long-Standing Childhood-Onset Type 1 Diabetes
por: Secrest, Aaron M., et al.
Publicado: (2010)

Haptoglobin Genotype and Renal Function Decline in Type 1 Diabetes
por: Costacou, Tina, et al.
Publicado: (2009)

Burden of Urological Complications in Men and Women With Long-standing Type 1 Diabetes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Cohort
por: Wessells, Hunter, et al.
Publicado: (2018)

Progression of Carotid Artery Intima-Media Thickness During 12 Years in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study
por: Polak, Joseph F., et al.
Publicado: (2011)

TXNIP DNA methylation is associated with glycemic control over 28 years in type 1 diabetes: findings from the Pittsburgh Epidemiology of Diabetes Complications (EDC) study
por: Miller, Rachel G, et al.
Publicado: (2023)

The Haptoglobin 1 Allele Correlates With White Matter Hyperintensities in Middle-Aged Adults With Type 1 Diabetes
por: Costacou, Tina, et al.
Publicado: (2015)

Relationship of Urologic Complications With Health-Related Quality of Life and Perceived Value of Health in Men and Women With Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Interventions and Complications (DCCT/EDIC) Cohort
por: Jacobson, Alan M., et al.
Publicado: (2015)

REDD1 Ablation Attenuates the Development of Renal Complications in Diabetic Mice
por: Sunilkumar, Siddharth, et al.
Publicado: (2022)

Serum Heat Shock Protein 27 and Diabetes Complications in the EURODIAB Prospective Complications Study : A Novel Circulating Marker for Diabetic Neuropathy
por: Gruden, Gabriella, et al.
Publicado: (2008)

Type A Behavior and Risk of All-Cause Mortality, CAD, and CAD-Related Mortality in a Type 1 Diabetic Population: 22 Years of Follow-up in the Pittsburgh Epidemiology of Diabetes Complications Study
por: Fickley, Catherine E., et al.
Publicado: (2013)

Clinically Relevant Cognitive Impairment in Middle-Aged Adults With Childhood-Onset Type 1 Diabetes
por: Nunley, Karen A., et al.
Publicado: (2015)

The Metabolic Syndrome and Microvascular Complications in a Murine Model of Type 2 Diabetes
por: Hur, Junguk, et al.
Publicado: (2015)

Impact of C-Peptide Preservation on Metabolic and Clinical Outcomes in the Diabetes Control and Complications Trial
por: Lachin, John M., et al.
Publicado: (2014)

miR-146a–Mediated Extracellular Matrix Protein Production in Chronic Diabetes Complications
por: Feng, Biao, et al.
Publicado: (2011)

Diabetes, Drug Treatment, and Mortality in COVID-19: A Multinational Retrospective Cohort Study
por: Nyland, Jennifer E., et al.
Publicado: (2021)

Correction of HDL Dysfunction in Individuals With Diabetes and the Haptoglobin 2-2 Genotype
por: Asleh, Rabea, et al.
Publicado: (2008)

Metabolic Phenotypes, Vascular Complications, and Premature Deaths in a Population of 4,197 Patients With Type 1 Diabetes
por: Mäkinen, Ville-Petteri, et al.
Publicado: (2008)

Therapeutic Effects of PPARα Agonists on Diabetic Retinopathy in Type 1 Diabetes Models
por: Chen, Ying, et al.
Publicado: (2013)

Glycemic Control and Cardiovascular Mortality in Hemodialysis Patients With Diabetes: A 6-Year Cohort Study
por: Ricks, Joni, et al.
Publicado: (2012)

Candesartan Attenuates Diabetic Retinal Vascular Pathology by Restoring Glyoxalase-I Function
por: Miller, Antonia G., et al.
Publicado: (2010)

Inflammation and Progressive Nephropathy in Type 1 Diabetes in the Diabetes Control and Complications Trial
por: Lin, Julie, et al.
Publicado: (2008)

Heparanase Is Essential for the Development of Diabetic Nephropathy in Mice
por: Gil, Natali, et al.
Publicado: (2012)

Vegfa Protects the Glomerular Microvasculature in Diabetes
por: Sivaskandarajah, Gavasker A., et al.
Publicado: (2012)

Skin Advanced Glycation End Products Glucosepane and Methylglyoxal Hydroimidazolone Are Independently Associated With Long-term Microvascular Complication Progression of Type 1 Diabetes
por: Genuth, Saul, et al.
Publicado: (2015)

Effect of Intensive Diabetes Therapy on the Progression of Diabetic Retinopathy in Patients With Type 1 Diabetes: 18 Years of Follow-up in the DCCT/EDIC
Publicado: (2015)

PPARγ Deacetylation Confers the Antiatherogenic Effect and Improves Endothelial Function in Diabetes Treatment
por: Liu, Longhua, et al.
Publicado: (2020)

Müller Glial Expression of REDD1 Is Required for Retinal Neurodegeneration and Visual Dysfunction in Diabetic Mice
por: Miller, William P., et al.
Publicado: (2022)

Mineralocorticoid Receptor Blockade Improves Coronary Microvascular Function in Individuals With Type 2 Diabetes
por: Garg, Rajesh, et al.
Publicado: (2015)

Heritability of Proliferative Diabetic Retinopathy
por: Hietala, Kustaa, et al.
Publicado: (2008)

Transcriptional Profiling of Diabetic Neuropathy in the BKS db/db Mouse: A Model of Type 2 Diabetes
por: Pande, Manjusha, et al.
Publicado: (2011)

Liver X Receptor Modulates Diabetic Retinopathy Outcome in a Mouse Model of Streptozotocin-Induced Diabetes
por: Hazra, Sugata, et al.
Publicado: (2012)

Impaired Collateral Recruitment and Outward Remodeling in Experimental Diabetes
por: van Golde, Jolanda M., et al.
Publicado: (2008)

A1C Variability and the Risk of Microvascular Complications in Type 1 Diabetes: Data from the Diabetes Control and Complications Trial
por: Kilpatrick, Eric S., et al.
Publicado: (2008)

Diabetic Nephropathy Is Accelerated by Farnesoid X Receptor Deficiency and Inhibited by Farnesoid X Receptor Activation in a Type 1 Diabetes Model
por: Wang, Xiaoxin X., et al.
Publicado: (2010)

Advanced Glycation End Products Predict Loss of Renal Function and Correlate With Lesions of Diabetic Kidney Disease in American Indians With Type 2 Diabetes
por: Saulnier, Pierre-Jean, et al.
Publicado: (2016)

Spinal Disinhibition in Experimental and Clinical Painful Diabetic Neuropathy
por: Marshall, Andrew G., et al.
Publicado: (2017)

Mitochondrial Calpain-1 Disrupts ATP Synthase and Induces Superoxide Generation in Type 1 Diabetic Hearts: A Novel Mechanism Contributing to Diabetic Cardiomyopathy
por: Ni, Rui, et al.
Publicado: (2016)

Toll-Like Receptor 4 Activation Contributes to Diabetic Bladder Dysfunction in a Murine Model of Type 1 Diabetes
por: Szasz, Theodora, et al.
Publicado: (2016)

Novel Detection and Restorative Levodopa Treatment for Preclinical Diabetic Retinopathy
por: Motz, Cara T., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8ptgipo2okn7qlv2j7kje2jimg